GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that declines with age
by pharmacies and mislabeled for research, or whether they are being purchased from chemical manufacturers, many located in China and not subject to FDA drug quality standards
These compounds are often obtained through unregulated sources that lack quality control
Subacute combined degeneration of the spinal cord , a serious complication of untreated B12 deficiency described in NHS and British Society for Haematology guidance, affects both the dorsal columns and corticospinal tracts
Its safety and efficacy in humans or animals have not been established
Patients with a history of suicidal ideation or attempts should be carefully evaluated before initiating treatment with Semaglutide / Cyanocobalamin Injection, as post-marketing reports have described occurrences of suicidal thoughts and behaviors in patients treated with GLP-1 receptor agonists